GenVec (GNVC) Rallies On Broker Call
GenVec (NASDAQ:GNVC) moved up 14% to $1.60 after Roth Capital initiated coverage of the stock with a “Buy” and a $4 stock price target, citing GenVec’s lead product, TNFerade, which is currently in a...
View ArticleGenVec Shows Again the Risks of Biotech Trophy Hunting (GNVC, ROSG, MRNA, CYCC)
We have covered over and over in recent months about the news flow of biotech and emerging biohealth companies creating an avenue that is causing traders to chase many speculative stocks up...
View Article
More Pages to Explore .....
